Commentaries
Recurrence rates in localized scleroderma (morphoea)
A. Kreuter,
A. Kreuter
Department of Dermatology, Allergology and Venereology, HELIOS St. Elisabeth Hospital, Josef Street 3, 46045 Oberhausen, Germany
Search for more papers by this author N. Hunzelmann,
N. Hunzelmann
Department of Dermatology, University of Cologne, Kerpener Street 62, 50937 Köln, Germany
Search for more papers by this author
A. Kreuter,
A. Kreuter
Department of Dermatology, Allergology and Venereology, HELIOS St. Elisabeth Hospital, Josef Street 3, 46045 Oberhausen, Germany
Search for more papers by this author N. Hunzelmann,
N. Hunzelmann
Department of Dermatology, University of Cologne, Kerpener Street 62, 50937 Köln, Germany
Search for more papers by this author
First published: 16 March 2015
No abstract is available for this article.
References
- 1Fett N, Werth VP. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 2011; 64: 217–28.
- 2Zwischenberger BA, Jacobe HT. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol 2011; 65: 925–41.
- 3Kreuter A, Krieg T, Worm M et al. AWMF Guideline no. 013/066. Diagnosis and therapy of circumscribed scleroderma. J Dtsch Dermatol Ges 2009; 7(Suppl. 6): S1–14 (in German).
- 4Yaqub A, Chung L, Rieger KE, Fiorentino DF. Localized cutaneous fibrosing disorders. Rheum Dis Clin North Am 2013; 39: 347–64.
- 5Mertens JS, Seyger MMB, Kievit W et al. Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with pediatric- or adult-onset disease. Br J Dermatol 2015; 172: 722–28.
